Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting-Reference-Cited by-同舟云学术

Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting

Published:2018-08-14 Issue:10 Volume:73 Page:2838-2845
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Niward Katarina¹²,Davies Forsman Lina³⁴,Bruchfeld Judith³⁴,Chryssanthou Erja⁵⁶,Carlström Oskar²,Alomari Teba²,Carlsson Björn⁷,Pohanka Anton⁸,Mansjö Mikael⁹,Jonsson Nordvall Michaela¹⁰,Johansson Anders G¹⁰,Eliasson Erik⁸,Werngren Jim⁹,Paues Jakob¹²,Simonsson Ulrika S H¹¹,Schön Thomas¹¹²

Affiliation:

1. Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

2. Department of Infectious Diseases, University Hospital Linköping, Linköping, Sweden

3. Department of Medicine Solna, Unit of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden

4. Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden

5. Department of Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden

6. Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

7. Department of Clinical Pharmacology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

8. Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden

9. Department of Microbiology, Public Health Agency of Sweden, Stockholm, Sweden

10. Department of Clinical Microbiology, University Hospital Linköping, Linköping, Sweden

11. Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

12. Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar, Sweden

Funder

Research Council of Southeast Sweden

Region of Östergötland

Marianne and Marcus Wallenberg Foundation

Swedish Heart and Lung Foundation

Swedish Research Council

Stockholm County Council

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/10/2838/25770421/dky268.pdf

Reference50 articles.

1. Serum drug concentrations predictive of pulmonary tuberculosis outcomes;Pasipanodya;J Infect Dis,2013

2. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis;Gillespie;N Engl J Med,2014

3. Therapeutic drug monitoring in the treatment of tuberculosis: an update;Alsultan;Drugs,2014

4. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana;Chideya;Clin Infect Dis,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective;Pharmaceutics;2024-03-12

2. Variability in plasma rifampicin concentrations and role of SLCO1B1 , ABCB1 , AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis;Infectious Diseases;2024-02-05

3. Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy;Microbiology Spectrum;2024-01-11

4. Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis;Tuberculosis;2023-05

5. Correlation between serum isoniazid concentration and therapeutic response in patients of pulmonary tuberculosis in Central India: A prospective observational study;Indian Journal of Tuberculosis;2023-04